An interventional study of Collaborative care and Consultations-Liaison in Panic Disorder, Generalized Anxiety Disorder and Social Phobia, sponsored by Amager Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-04.
Sponsored by Amager Hospital · Not applicable, Interventional, and Treatment
The aim of the study Collabri Flex is to:
The Collabri Flex model for Collaborative Care takes point of departure in the earlier study Collabri. It is changed according to gathered information under the first study of the Collabri model in order to achieve a Danish Collaborative Care model easier to implement.
The aims of Project Collabri Flex are to:
In Collabri the treatment is in line with a set of general treatment principles relevant for collaborative care interventions. The patients in the intervention group are offered cognitive behavioral therapy (CBT), psychoeducation and medication according to at stepped care model by a care manager refering to the general practitioner.
The Collabri Flex study is set up as a researcher-blinded individually randomized controlled trial with participation of an intervention group (treatment according to the Collabri Flex model) and a consultation liaison group.
This study will contribute with new knowledge on collaborative care interventions in a Scandinavian context.
Exclusion Criteria:
For patients in the Collabri Flex group:
Collaborative care
Behavioral: Collaborative care
Consultations with general practitioner
Behavioral: Consultations-Liaison
Collaborative care provided by the general practitioner and the care manager. Treatment modalities: Cognitive-behavior Therapy, psychoeducation, medication according to a stepped care model
Consultation-Liaison provided by general practitioner involving a educational relationship with the Collabri Flex team (care manager and psychiatrist).
Self-reported degree of anxiety
Measured by Beck Anxiety Inventory (BAI)
Time frame: 6 months
Self-reported degree of depression
Measured by Beck Depression Inventory (BDI-II)
Time frame: 6 months
Self-reported pychological stress
Measured by the Symptom Checklist SCL-90-R
Time frame: 6 months
Self-reported functional impairment
Measured by Sheehan Disability Scale (SDS)
Time frame: 6 months
Self-reported quality of life/well-being
Measured by WHO-5
Time frame: 6 months
Sick leave
Obtained from the DREAM database
Time frame: 6 months
Sick leave
Obtained from the DREAM database
Time frame: 18 months
Self-reported self-efficacy
Measured by the IPQ-R Scale (Personal control) and two subscales from the Chronic disease Selv-Efficacy Scales (SECD-32); Obtain help from Community, Family, Friends Scale and control Manage Depression Scale
Time frame: 6 months
Self-reported self-efficacy
Measured by the IPQ-R Scale (Personal control) and two subscales from the Chronic disease Selv-Efficacy Scales (SECD-32); Obtain help from Community, Family, Friends Scale and control Manage Depression Scale
Time frame: 18 months
Self-reported health-related quality of life
Measured by EQ-5D
Time frame: 6 months
Self-reported health-related quality of life
Measured by EQ-5D
Time frame: 18 months
Employment
Obtained from the DREAM database
Time frame: 6 months
Employment
Obtained from the DREAM database
Time frame: 18 months
Mental-health outpatient services
National patient register
Time frame: 6 months
Mental-health outpatient services
National patient register
Time frame: 18 months
Experience of support in recovery
Self-reported support in recovery (INSPIRE)
Time frame: 6 months
Patient satisfaction
Self-reported satisfaction with treatment (CSQ-8)
Time frame: 6 months
Self-reported degree of anxiety
Measured by Beck Anxiety Inventory (BAI)
Time frame: 18 months
Self-reported degree of depression
Measured by Beck Depression Inventory (BDI-II)
Time frame: 18 months
Self-reported pychological stress
Measured by the Symptom Checklist SCL-90-R
Time frame: 18 months
Self-reported functional impairment
Measured by Sheehan Disability Scale (SDS)
Time frame: 18 months
Self-reported quality of life/well-being
Measured by WHO-5
Time frame: 18 months
Plan to share: Undecided
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Amager Hospital